Skip to content

Clinical trials

Respiratory Tract Diseases trials in Australia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Respiratory Tract Diseases Country / region: Australia Clear all

31 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20093
20112
20131
20142
20151
20163
20174
20181
20194
20201
20211
20222
20231
20242
20252
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed15
Active, not recruiting7
Recruiting4
Terminated3
Enrolling by invitation1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca4
Eli Lilly and Company3
Respira Therapeutics, Inc.2
Revolution Medicines, Inc.2
United Therapeutics2
Vertex Pharmaceuticals Incorporated2
AIRNA Corporation1
Bayer1
Bellus Health Inc. - a GSK company1
Celgene1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Respiratory Tract Diseases31
Lung Diseases27
Carcinoma, Non-Small-Cell Lung8
Lung Neoplasms8
Neoplasms8
Neoplasms by Site8
Respiratory Tract Neoplasms8
Thoracic Neoplasms7
Bronchial Diseases6
Bronchial Neoplasms6

Trials

Showing 1 to 25 of 31. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.